Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.2, 2001-02, pp. : 129-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EARTH: Endothelin_A Receptor Antagonist Trial in Heart Failure

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 294-298

Karger

Access to resources Recommend Favorite

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M Widlitz Allison C Barst Robyn J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite

Tolerability, pharmacokinetics, and pharmacodynamics of clazosentan, a parenteral endothelin receptor antagonist

By Giersbergen Paul Dingemanse Jasper

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

By Morse G.D.

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite

Single- and Multiple-Dose Pharmacokinetics and Tolerability of Gepirone Extended-Release

By Timmer C.J.

Clinical Drug Investigation, Vol. 22, Iss. 12, 2002-01 ,pp. : 819-826

Adis International

Access to resources Recommend Favorite